Helius Therapeutics, the country’s largest licensed medical cannabis producer, expects industry-wide sales will nearly double this year based on 2022 growth rates.
Helius chief executive Carmen Doran – who is also a member of the industry body, the NZ Medical Cannabis Council – said she was
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
